However, accumulating evidence over the past two decades demonstrates that a biomarker called C-reactive protein —which signals the presence of low-grade inflammation—is a better predictor of risk for ...
The author(s) indicated no potential conflicts of interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback